ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Cyxone Inks API Deal with European CDMO
January 20, 2022Takes next step in multiple sclerosis program engaging CDMO for production of drug candidate T20K. -
Cyxone appoints Henrik Hang as CFO
June 10, 2021Cyxone AB (publ) (“Cyxone or the Company”) has appointed Henrik Hang as new CFO as of August 1st, 2021. Henrik has a degree in business administration and substantial experience from many years as CFO for international companies listed on First North Grow -
Cyxone Explores Orphan Drug Designation for Rabeximod
September 09, 2019Cyxone announced the company's board of directors has decided to explore the possibilities of an orphan drug designation (ODD) of the drug candidate Rabeximod. -
Cyxone Submits First Application to Start Rabeximod Clinical Trial
July 08, 2019Cyxone has submitted an application to the Central Ethics Committee (CEC) in Poland for permission to start a clinical phase IIb trial with its drug candidate Rabeximod, which is in development for the treatment of rheumatoid arthritis (RA).
Pharma Sources Insight January 2025
